BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30588242)

  • 1. Overexpression of FNDC1 in Gastric Cancer and its Prognostic Significance.
    Ren J; Niu G; Wang X; Song T; Hu Z; Ke C
    J Cancer; 2018; 9(24):4586-4595. PubMed ID: 30588242
    [No Abstract]   [Full Text] [Related]  

  • 2. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FNDC1 is highly expressed in lung adenocarcinoma and closely related with poor prognosis].
    Hong H; Zhu H; Li C; Zang C; Sang H; Chen L; Wang A
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1182-1190. PubMed ID: 36073217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High FNDC1 expression correlates with poor prognosis in gastric cancer.
    Zhong M; Zhang Y; Yuan F; Peng Y; Wu J; Yuan J; Zhu W; Zhang Y
    Exp Ther Med; 2018 Nov; 16(5):3847-3854. PubMed ID: 30402143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Kin of IRRE-Like Protein 1 (KIRREL) in Gastric Cancer and Its Clinical Prognostic Significance.
    Zhang MJ; Hong YY; Li N
    Med Sci Monit; 2018 May; 24():2711-2719. PubMed ID: 29717104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of KIF23 expression in gastric cancer.
    Liang WT; Liu XF; Huang HB; Gao ZM; Li K
    World J Gastrointest Oncol; 2020 Oct; 12(10):1104-1118. PubMed ID: 33133380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FNDC1 Promotes the Invasiveness of Gastric Cancer
    Jiang T; Gao W; Lin S; Chen H; Du B; Liu Q; Lin X; Chen Q
    Front Oncol; 2020; 10():590492. PubMed ID: 33392086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
    Li J; Su T; Yang L; Zhang C; He Y
    Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of FNDC1 Relates to Poor Prognosis and Its Knockdown Impairs Cell Invasion and Migration in Gastric Cancer.
    Liu YP; Chen WD; Li WN; Zhang M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819869928. PubMed ID: 31530096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Martrilin-3 (MATN3) Overexpression in Gastric Adenocarcinoma and its Prognostic Significance.
    Wu PL; He YF; Yao HH; Hu B
    Med Sci Monit; 2018 Jan; 24():348-355. PubMed ID: 29343680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer.
    Zhang LH; Wang Z; Li LH; Liu YK; Jin LF; Qi XW; Zhang C; Wang T; Hua D
    World J Clin Cases; 2019 Aug; 7(15):1954-1963. PubMed ID: 31423427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of FNDC1 suppresses gastric cancer progression by interfering with Gβγ-VEGFR2 complex formation.
    Lu Y; Huang P; Zeng X; Liu W; Zhao R; Li J; Cao G; Hu Y; Xiao Q; Wu M; Huang W; Tang X; Liu X; Wei H
    iScience; 2023 Sep; 26(9):107534. PubMed ID: 37670789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses.
    Wu KZ; Xu XH; Zhan CP; Li J; Jiang JL
    World J Gastrointest Oncol; 2020 Sep; 12(9):975-991. PubMed ID: 33005292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
    Li X; He J; Yu M; Zhang W; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of thrombospondin gene family in gastric cancer.
    Deng LY; Zeng XF; Tang D; Deng W; Liu HF; Xie YK
    J Gastrointest Oncol; 2021 Apr; 12(2):355-364. PubMed ID: 34012631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
    Ma X; Wang J; Zhao M; Huang H; Wu J
    Oncol Lett; 2019 Jul; 18(1):465-471. PubMed ID: 31289518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.